Athersys Inc at Bank of America Healthcare Conference Transcript
Welcome to the afternoon session of day 2 of the Bank of America Healthcare Conference. My name is Greg Harrison. I'm one of the biotech analysts here at Bank of America. It's my pleasure today to introduce Dan Camardo, Chief Executive Officer of Athersys; and Ivor Macleod, Chief Financial Officer.
Dan, would you like to start off with some opening remarks, and then we can jump into Q&A?
Sure. Thanks, Greg. Thanks for having us. And for myself and Ivor and the rest of the team at Athersys, this is an important day but also leading to an important milestone that we're working towards coming up in the next few weeks regarding an output of our partner's Phase III trial results in stroke called the TREASURE trial.
I think that just from the other companies that I've seen here, I would probably say Athersys might be one of the most unknown stories that are out here visiting in Las Vegas. And I think we have a really
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |